Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for Therapy?

Korean Circ J. 2020 Sep;50(9):817-821. doi: 10.4070/kcj.2020.0287.

Authors

Hyun Kuk Kim¹, Udaya S Tantry², Paul A Gurbel², Young Hoon Jeong³

Affiliations

¹ Department of Internal Medicine, Chosun University School of Medicine, Chosun University Hospital, Gwangju, Korea.
² Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, USA.
³ Department of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, Korea. goodoctor@naver.com.

No abstract available

Publication types

Editorial

Grants and funding

NRF-2015R1A5A2008833/NRF/National Research Foundation of Korea/Korea